Apyx Medical Corporation (APYX)
USD 1.25
(16.82%)
USD 1.25
(16.82%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 51.01 Million USD | -35.34% |
| 2022 | 52.69 Million USD | 9.67% |
| 2021 | 48.04 Million USD | 27.83% |
| 2020 | 37.58 Million USD | -6.12% |
| 2019 | 40.03 Million USD | 69.28% |
| 2018 | 23.65 Million USD | 0.64% |
| 2017 | 23.5 Million USD | 8.27% |
| 2016 | 21.7 Million USD | 11.07% |
| 2015 | 19.54 Million USD | 31.68% |
| 2014 | 14.84 Million USD | 32.23% |
| 2013 | 11.22 Million USD | 9.11% |
| 2012 | 10.28 Million USD | -10.54% |
| 2011 | 11.49 Million USD | 0.39% |
| 2010 | 11.45 Million USD | 2.82% |
| 2009 | 11.13 Million USD | 5.52% |
| 2008 | 10.55 Million USD | 14.64% |
| 2007 | 9.2 Million USD | 15.45% |
| 2006 | 7.97 Million USD | 11.44% |
| 2005 | 7.15 Million USD | 6.8% |
| 2004 | 6.7 Million USD | 4.66% |
| 2003 | 6.4 Million USD | 11.76% |
| 2002 | 5.73 Million USD | 10.7% |
| 2001 | 5.17 Million USD | 7.61% |
| 2000 | 4.81 Million USD | -32.79% |
| 1999 | 7.15 Million USD | 75.08% |
| 1998 | 4.08 Million USD | 41.31% |
| 1997 | 2.89 Million USD | 0.76% |
| 1996 | 2.87 Million USD | 13.7% |
| 1995 | 2.52 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 8.35 Million USD | 32.79% |
| 2024 Q1 | 6.29 Million USD | -36.02% |
| 2023 FY | 34.07 Million USD | -35.34% |
| 2023 Q1 | 13.18 Million USD | -6.98% |
| 2023 Q4 | 9.83 Million USD | 60.83% |
| 2023 Q3 | 6.11 Million USD | -53.68% |
| 2023 Q2 | 13.2 Million USD | 0.17% |
| 2022 Q3 | 11.53 Million USD | -10.48% |
| 2022 FY | 52.69 Million USD | 9.67% |
| 2022 Q4 | 14.17 Million USD | 22.84% |
| 2022 Q2 | 12.89 Million USD | -8.52% |
| 2022 Q1 | 14.09 Million USD | 1.78% |
| 2021 Q4 | 13.84 Million USD | 15.13% |
| 2021 FY | 48.04 Million USD | 27.83% |
| 2021 Q1 | 10.6 Million USD | 8.72% |
| 2021 Q2 | 11.57 Million USD | 9.17% |
| 2021 Q3 | 12.02 Million USD | 3.86% |
| 2020 FY | 37.58 Million USD | -6.12% |
| 2020 Q3 | 9.09 Million USD | 10.11% |
| 2020 Q2 | 8.26 Million USD | -21.14% |
| 2020 Q1 | 10.47 Million USD | -9.09% |
| 2020 Q4 | 9.75 Million USD | 7.23% |
| 2019 Q1 | 8.92 Million USD | 12.48% |
| 2019 FY | 40.03 Million USD | 69.28% |
| 2019 Q4 | 11.52 Million USD | 18.63% |
| 2019 Q3 | 9.71 Million USD | 8.69% |
| 2019 Q2 | 8.93 Million USD | 0.16% |
| 2018 Q1 | 5.85 Million USD | 7.16% |
| 2018 Q3 | 5.31 Million USD | -18.75% |
| 2018 Q4 | 7.93 Million USD | 49.2% |
| 2018 FY | 23.65 Million USD | 0.64% |
| 2018 Q2 | 6.54 Million USD | 11.79% |
| 2017 Q3 | 5.72 Million USD | -9.77% |
| 2017 FY | 23.5 Million USD | 8.27% |
| 2017 Q2 | 6.34 Million USD | 6.46% |
| 2017 Q1 | 5.96 Million USD | 1.52% |
| 2017 Q4 | 5.46 Million USD | -4.63% |
| 2016 Q4 | 5.87 Million USD | 10.68% |
| 2016 Q3 | 5.3 Million USD | 1.86% |
| 2016 Q2 | 5.21 Million USD | -1.99% |
| 2016 Q1 | 5.31 Million USD | 9.2% |
| 2016 FY | 21.7 Million USD | 11.07% |
| 2015 FY | 19.54 Million USD | 31.68% |
| 2015 Q4 | 4.86 Million USD | -3.45% |
| 2015 Q3 | 5.04 Million USD | 7.55% |
| 2015 Q2 | 4.68 Million USD | -5.22% |
| 2015 Q1 | 4.94 Million USD | 16.84% |
| 2014 Q2 | 3.62 Million USD | 34.28% |
| 2014 Q1 | 2.69 Million USD | -5.17% |
| 2014 Q3 | 4.28 Million USD | 18.3% |
| 2014 FY | 14.84 Million USD | 32.23% |
| 2014 Q4 | 4.23 Million USD | -1.24% |
| 2013 Q3 | 2.72 Million USD | -4.05% |
| 2013 FY | 11.22 Million USD | 9.11% |
| 2013 Q4 | 2.84 Million USD | 4.44% |
| 2013 Q2 | 2.83 Million USD | 0.82% |
| 2013 Q1 | 2.81 Million USD | 5.9% |
| 2012 Q2 | 2.61 Million USD | 9.0% |
| 2012 Q3 | 2.61 Million USD | -0.15% |
| 2012 FY | 10.28 Million USD | -10.54% |
| 2012 Q4 | 2.65 Million USD | 1.8% |
| 2012 Q1 | 2.4 Million USD | -40.7% |
| 2011 Q4 | 4.04 Million USD | 71.63% |
| 2011 Q3 | 2.35 Million USD | -5.53% |
| 2011 Q1 | 2.59 Million USD | -10.74% |
| 2011 Q2 | 2.49 Million USD | -3.93% |
| 2011 FY | 11.49 Million USD | 0.39% |
| 2010 FY | 11.45 Million USD | 2.82% |
| 2010 Q3 | 2.81 Million USD | -9.3% |
| 2010 Q4 | 2.91 Million USD | 3.25% |
| 2010 Q2 | 3.1 Million USD | 18.75% |
| 2010 Q1 | 2.61 Million USD | -5.97% |
| 2009 Q1 | 2.77 Million USD | -6.99% |
| 2009 Q4 | 2.78 Million USD | -3.04% |
| 2009 Q3 | 2.87 Million USD | 6.1% |
| 2009 Q2 | 2.7 Million USD | -2.59% |
| 2009 FY | 11.13 Million USD | 5.52% |
| 2008 Q4 | 2.98 Million USD | 13.93% |
| 2008 Q2 | 2.65 Million USD | 15.59% |
| 2008 Q1 | 2.29 Million USD | 2.67% |
| 2008 FY | 10.55 Million USD | 14.64% |
| 2008 Q3 | 2.62 Million USD | -1.29% |
| 2007 Q1 | 2.09 Million USD | -4.71% |
| 2007 Q2 | 2.45 Million USD | 17.45% |
| 2007 Q4 | 2.23 Million USD | -6.99% |
| 2007 Q3 | 2.4 Million USD | -2.12% |
| 2007 FY | 9.2 Million USD | 15.45% |
| 2006 Q2 | 2.18 Million USD | 35.32% |
| 2006 Q3 | 2.05 Million USD | -5.99% |
| 2006 Q4 | 2.19 Million USD | 7.09% |
| 2006 FY | 7.97 Million USD | 11.44% |
| 2006 Q1 | 1.61 Million USD | -16.73% |
| 2005 FY | 7.15 Million USD | 6.8% |
| 2005 Q3 | 1.94 Million USD | 13.43% |
| 2005 Q4 | 1.93 Million USD | -0.56% |
| 2005 Q1 | 1.56 Million USD | -10.38% |
| 2005 Q2 | 1.71 Million USD | 9.42% |
| 2004 FY | 6.7 Million USD | 4.66% |
| 2004 Q1 | 1.59 Million USD | -21.37% |
| 2004 Q2 | 1.78 Million USD | 11.57% |
| 2004 Q3 | 1.74 Million USD | -2.14% |
| 2004 Q4 | 1.74 Million USD | 0.38% |
| 2003 FY | 6.4 Million USD | 11.76% |
| 2003 Q2 | 1.49 Million USD | 0.07% |
| 2003 Q1 | 1.49 Million USD | 0.89% |
| 2003 Q4 | 2.03 Million USD | 46.87% |
| 2003 Q3 | 1.38 Million USD | -7.6% |
| 2002 Q2 | 1.26 Million USD | -7.57% |
| 2002 FY | 5.73 Million USD | 10.7% |
| 2002 Q4 | 1.48 Million USD | -8.38% |
| 2002 Q3 | 1.61 Million USD | 28.0% |
| 2002 Q1 | 1.36 Million USD | -30.37% |
| 2001 Q2 | 1.02 Million USD | -9.87% |
| 2001 Q4 | 1.96 Million USD | 85.66% |
| 2001 Q3 | 1.05 Million USD | 3.48% |
| 2001 Q1 | 1.13 Million USD | -36.28% |
| 2001 FY | 5.17 Million USD | 7.61% |
| 2000 Q1 | 1.05 Million USD | 0.0% |
| 2000 Q2 | 911.11 Thousand USD | -13.39% |
| 2000 Q3 | 1.06 Million USD | 17.17% |
| 2000 FY | 4.81 Million USD | -32.79% |
| 2000 Q4 | 1.77 Million USD | 66.67% |
| 1999 FY | 7.15 Million USD | 75.08% |
| 1998 FY | 4.08 Million USD | 41.31% |
| 1997 FY | 2.89 Million USD | 0.76% |
| 1996 FY | 2.87 Million USD | 13.7% |
| 1995 FY | 2.52 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdaptHealth Corp. | 1.07 Billion USD | 95.267% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 73.355% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 9.827% |
| BrainsWay Ltd. | 28.01 Million USD | -82.09% |
| Cerus Corporation | 143.15 Million USD | 64.362% |
| CVRx, Inc. | 76.14 Million USD | 32.996% |
| electroCore, Inc. | 32.03 Million USD | -59.277% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -707.465% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -311.045% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -308.503% |
| Orthofix Medical Inc. | 667.42 Million USD | 92.356% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 74.913% |
| iCAD, Inc. | 22.22 Million USD | -129.552% |
| IceCure Medical Ltd | 16.87 Million USD | -202.311% |
| 908 Devices Inc. | 68.08 Million USD | 25.062% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -335.196% |
| Movano Inc. | 29.69 Million USD | -71.836% |
| MaxCyte, Inc. | 84.84 Million USD | 39.869% |
| Nexalin Technology, Inc. | 5.78 Million USD | -782.457% |
| PAVmed Inc | 64.82 Million USD | 21.301% |
| Insulet Corporation | 939.9 Million USD | 94.572% |
| Quanterix Corporation | 118.1 Million USD | 56.801% |
| RxSight, Inc. | 103.85 Million USD | 50.873% |
| Sight Sciences, Inc. | 126.44 Million USD | 59.653% |
| Sintx Technologies, Inc. | 15.2 Million USD | -235.623% |
| Surmodics, Inc. | 98.69 Million USD | 48.308% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 27.175% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -104.514% |
| Venus Concept Inc. | 80.47 Million USD | 36.605% |
| NeuroPace, Inc. | 75.29 Million USD | 32.243% |
| LENSAR, Inc. | 33.33 Million USD | -53.042% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 0.117% |
| SI-BONE, Inc. | 156.35 Million USD | 67.37% |
| TELA Bio, Inc. | 84.18 Million USD | 39.399% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -497.961% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -20.235% |
| LivaNova PLC | 843.54 Million USD | 93.952% |
| Bioventus Inc. | 409.91 Million USD | 87.554% |
| Envoy Medical, Inc. | 17.89 Million USD | -185.049% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 62.834% |
| Spectral AI, Inc. | 20.86 Million USD | -144.526% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 8.892% |
| Aethlon Medical, Inc. | 12.27 Million USD | -315.54% |
| Inogen, Inc. | 236.08 Million USD | 78.39% |
| OrthoPediatrics Corp. | 137.01 Million USD | 62.766% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 89.45% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1346.09% |
| Cutera, Inc. | 197.72 Million USD | 74.197% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -105.875% |
| BioSig Technologies, Inc. | 28.53 Million USD | -78.822% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -41.481% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 93.9% |
| Axonics, Inc. | 270.2 Million USD | 81.119% |
| Outset Medical, Inc. | 198.77 Million USD | 74.333% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -189.332% |
| IRIDEX Corporation | 31.81 Million USD | -60.363% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 71.691% |
| IRadimed Corporation | 30.12 Million USD | -69.367% |
| INVO Bioscience, Inc. | 7.85 Million USD | -549.638% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 48.18% |
| Varex Imaging Corporation | 224.8 Million USD | 77.305% |
| Quipt Home Medical Corp. | 148.66 Million USD | 65.683% |
| BIOLASE, Inc. | 34.66 Million USD | -47.191% |
| Beyond Air, Inc. | 61.7 Million USD | 17.313% |
| Pulmonx Corporation | 112.68 Million USD | 54.726% |
| Modular Medical, Inc. | 17.52 Million USD | -191.049% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -152.727% |
| FONAR Corporation | 28.6 Million USD | -78.355% |
| Semler Scientific, Inc. | 38.94 Million USD | -31.003% |
| InMode Ltd. | 215.68 Million USD | 76.346% |
| Bruker Corporation | 1.07 Billion USD | 95.26% |
| Cytosorbents Corporation | 48.33 Million USD | -5.547% |
| DexCom, Inc. | 1.69 Billion USD | 96.983% |
| Align Technology, Inc. | 2.07 Billion USD | 97.543% |
| ZimVie Inc. | 275.12 Million USD | 81.456% |
| Nexalin Technology, Inc. | 5.78 Million USD | -782.457% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1346.09% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 91.51% |
| Profound Medical Corp. | 33.6 Million USD | -51.825% |
| Vivani Medical, Inc. | 26.96 Million USD | -89.201% |
| enVVeno Medical Corporation | 25.23 Million USD | -102.148% |
| Inari Medical, Inc. | 448.59 Million USD | 88.627% |
| UFP Technologies, Inc. | 58.08 Million USD | 12.173% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -935.352% |
| Nuwellis, Inc. | 22.61 Million USD | -125.614% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 88.558% |
| InspireMD, Inc. | 22.95 Million USD | -122.301% |
| PAVmed Inc. | 64.82 Million USD | 21.301% |
| AxoGen, Inc. | 149.33 Million USD | 65.837% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 71.191% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -15.68% |
| Tenon Medical, Inc. | 16.96 Million USD | -200.672% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -590.085% |
| NanoVibronix, Inc. | 4.97 Million USD | -925.9% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -335.196% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -253.261% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 87.007% |
| TransMedics Group, Inc. | 182.82 Million USD | 72.094% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -81.785% |
| NeuroMetrix, Inc. | 11.09 Million USD | -359.666% |
| Hyperfine, Inc. | 52.87 Million USD | 3.507% |
| Establishment Labs Holdings Inc. | 172 Million USD | 70.339% |
| Biomerica, Inc. | 6.97 Million USD | -631.126% |
| Bone Biologics Corporation | 9.42 Million USD | -441.115% |
| AVITA Medical, Inc. | 80.77 Million USD | 36.843% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -394.782% |
| Silk Road Medical, Inc | 186.35 Million USD | 72.624% |